Case study on Anemia.ppt

22,054 views 12 slides Mar 31, 2022
Slide 1
Slide 1 of 12
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12

About This Presentation

case study on Anemia


Slide Content

Department of pharmacy practice
Case study on Anemia& vitamin-D
Deficiency
PRESENTED BY:
NAME:JEEVA P
REG NO :P1520004
PHARM.D (P.B) IIYEAR

A 23 years female patient was admitted in the hospital.
C/O:
Pain in right hip for 1 year
Breathlessness on exertion 1 year
History of present illness: patient was apparently asymptomatic when she developed pain in
the right hip for past 1 year insidious in onset,progressivein nature,radiatedto back,
aggravated on walking and relieving radiated in rest.Thepain has increased in severity over
the past 4 month. The past also c/o breathlessness on exertion for past 1 year.Insidiousin
onset,notassociated with noisy breathing,cough. No H\O palpitation ,syncope.
Past Medical History : No known comorbids
Past Medication History : NIL
Family History : Nil
Social History : Nil
2
SUBJECTIVE EVIDENCES

Physical examination:
Patient is conscious, oriented,
Temp-Afebrile
Pulse-102 beats/min
BP-100/60mmHg↓
RR-22 breaths/min
Pallor +
Short statured,koilonychia+, Arm span -138cm
Systemic examination:
CVS-S1S2+ no murmurus
RS-BAE+
CNS-NFND+
P/A-Soft
3
OBJECTIVE EVIDENCES

4
Laboratory investigations:
mh
OBJECTIVE EVIDENCES
PARAMETERS OBSERVED VALUE NORMAL RANGE
HEMATOLOGICAL
HAEMOGLOBIN 7.2 13-17 g/dl
MCV 66.7 83-101 fl
MCH 16.8 27-32 pg
PCV 28.6 41-59 %
MCHC 25.2 31-35
Other special test:
Calcium 8.3 8.6-10.3 mg/dL
phosphate 2.8 2.8 to 4.5 mg/dL
PERPHERAL SMEAR: RBC: Microcytic hypochromicwith Short statured,
koilonychia +, Arm span -138cm.

5
ASSESSMENT
•Iron Deficiency Anemia
•Vitamin D Deficiency

DRUG DOSE ROAFREQ
Y
DAY(s)
1 2 3 4 5 6
T.paracetamol 500mg P/OTDS *** * * *
T. shelcal
(calcium with D
3)
500mg P/O BD -** * * *
Inj.Enficer
(Iron sucrose )
200mg IV OD -** * * *
T.FolicAcid 5mg P/O BD *** * * *
T.NeurobionForte1mg P/O OD --- * * *
6
PLAN

Drug -drug interaction :NIL
Drug -food interaction : NIL
Adverse Reaction : NIL
Medication Error : NIL
GUIDELINE : For IDA, INJ.ENCIFER and T.folicacid were given by the ASH
(American Society of Haematology).
According to the guideline the given drugs are completely appropriate.
For vitamin D deficiency,Accordingto the ICMR guidelines the given drug are
appropriate.
7
CRITICAL CARE ANALYSIS

Pharmacist Intervention
The given drug T.PARA 500mg was continued even after the
indication ceased and it was stopped after the pharmacist
intervened.
8

Regardingdisease:
Irondeficiencyanemiaisthemostcommontypeofanemia,
anditoccurswhenyourbodydoesn'thaveenoughofthe
mineraliron.
Bodyneedsirontomakehemoglobin.Whenthereisn'tenough
ironinyourbloodstream,therestofyourbodycan'tgetthe
amountofoxygenitneed
9
PATIENT COUNSELING

Regardingdrugs:
T.PARAisgivenforthepainthatyouhaveinyourhip.
T.Shelcalwillhelpincreasecalciumcontentinyourbody
Inj.Enciferisgivenforincreasingtheironcontentinyourbody.
T.Folicacidisgivenforincreasingtheironproteinlevelinblood.
T.Neurobionforteareadvicedisgivenforthevitaminsupplement
andpaininthehip.
10
PATIENT COUNSELING

Regardinglifestylemodification:
Anemiaisaconditioninwhichyoulackenoughhealthyredbloodcellstocarry
adequateoxygentoyourbody'stissues.
Besuretodrinkplentyoffluidstoreducedehydrationandincludefruits,
vegetables,andfibreinyourdieteachday.
Ironpillsoftenmakeyourbowelmovementsdarkorgreen.
Ifyouforgettotakeanironpill,donottakeadoubledoseofironthenexttimeyou
takeapill.
Keepironpillsoutofthereachofsmallchildren.
Regularmedicalcheckupandtreatmentareimportant.
11
PATIENT COUNSELING

12
Tags